Use of FGFR1 extra cellular domain proteins to treat cancers characterized by ligand-dependent activating mutations in FGFR2
Details for Australian Patent Application No. 2010319327 (hide)
International Classifications
Event Publications
31 May 2012 PCT application entered the National Phase
PCT publication WO2011/060333 Priority application(s): WO2011/060333
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2010319328-Dry powder inhaler with flutter dispersion member
2010319323-Immunomodulatory methods and systems for treatment and/or prevention of atherosclerosis
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser